Purchase Order HHSN268201200059P

<p>The National Heart Lung and Blood Institute awarded a purchase order to Roche Diagnostics Corporation valued at $25,138.89 on December 24, 2013, with completion by August 1, 2014. Performance occurs at North Bethesda, Maryland. The order is firm fixed price for in vitro diagnostic equipment, reagents, or laboratory instruments supplied by the vendor to support the Institute's clinical and research operations.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Roche Diagnostics Corporation for $25,138.89 on December 23, 2013, with completion by July 17, 2014. Place of performance is North Bethesda, Maryland. The order is priced firm fixed price for in vitro diagnostic supplies and reagents supporting the Institute's clinical laboratory operations.</p>

<p>The National Heart Lung and Blood Institute issued a purchase order to Roche Diagnostics Corporation valued at $40,000.00 on February 1, 2013, with ultimate completion on January 31, 2014.</p> <p>Performance takes place in Bethesda, Maryland. The order carries firm fixed-price pricing with no set-aside designation. Roche Diagnostics supplies in vitro diagnostic products, laboratory instruments, reagents, and associated medical technologies to federal healthcare agencies.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Roche Diagnostics Corporation valued at $33,333.33 on April 29, 2013, with completion by January 16, 2014. Performance takes place in Bethesda, Maryland. The order is firm fixed-price with no set-aside applied. The source does not specify the goods or services procured.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Li-Cor, Inc. for maintenance, repair, and rebuild of laboratory instruments and equipment with a ceiling value of $3,600.00 on January 19, 2012. The order carries firm fixed-price pricing with ultimate completion scheduled for January 19, 2013. Performance is located in Bethesda, Maryland. No set-aside designation was used for this acquisition.</p>

<p>The National Heart Lung and Blood Institute issued a purchase order to Rees Scientific Corporation on October 27, 2011, for maintenance, repair, and rebuild of laboratory instruments and equipment, with a ceiling value of $6,065.20 and firm fixed-price terms. Performance occurs in Bethesda, Maryland, with ultimate completion by November 1, 2012. No set-aside applies to this simplified acquisition.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Rees Scientific Corporation on June 14, 2011, for maintenance and repair of instruments and laboratory equipment, with a ceiling value of $8,200.55 and an ultimate completion date of June 30, 2012.</p> <p>Work is performed at Bethesda, Maryland. The order carries firm fixed-price pricing and no set-aside designation.</p>

<p>The National Heart Lung and Blood Institute issued a purchase order to Life Technologies Corporation for $7,341.84 on December 9, 2013, with completion on December 9, 2014. The order covers a maintenance agreement, with place of performance in Bethesda, Maryland. Pricing is firm fixed price with no small business set-aside.</p>

<p>The National Heart Lung and Blood Institute issued a purchase order to Applied Biosystems, LLC (operating as Life Technologies) on July 13, 2011, for maintenance and repair of instruments and laboratory equipment, with a ceiling value of $7,035.84 and an ultimate completion date of September 28, 2012. Work is performed in Bethesda, Maryland. The order carries firm fixed price terms and no small business set-aside.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Coherent Inc. valued at $14,700 on January 18, 2012, for maintenance, repair, and rebuild of laboratory instruments and equipment. Performance occurs at Bethesda, Maryland. The order carries a firm fixed-price structure with an ultimate completion date of January 18, 2013. No small business set-aside applies.</p>